Single-cell RNA sequencing revealed potential targets for immunotherapy studies in hepatocellular carcinoma
Abstract Hepatocellular carcinoma (HCC) is a solid tumor prone to chemotherapy resistance, and combined immunotherapy is expected to bring a breakthrough in HCC treatment. However, the tumor and tumor microenvironment (TME) of HCC is highly complex and heterogeneous, and there are still many unknown...
Main Authors: | Zhouhua Xie, Jinping Huang, Yanjun Li, Qingdong Zhu, Xianzhen Huang, Jieling Chen, Cailing Wei, Shunda Luo, Shixiong Yang, Jiamin Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-46132-w |
Similar Items
-
Integrated analysis revealing a novel stemness-metabolism-related gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma
by: Yuxin Wang, et al.
Published: (2023-08-01) -
Single-cell RNA sequencing reveals cell subpopulations in the tumor microenvironment contributing to hepatocellular carcinoma
by: Jiamin Gao, et al.
Published: (2023-06-01) -
Unveiling the Role of Tumor-Infiltrating T Cells and Immunotherapy in Hepatocellular Carcinoma: A Comprehensive Review
by: Xiaokun Chen, et al.
Published: (2023-10-01) -
Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing?
by: Antonella Cammarota, et al.
Published: (2023-01-01) -
Single-cell sequencing and bulk RNA sequencing reveal a cell differentiation-related multigene panel to predict the prognosis and immunotherapy response of hepatocellular carcinoma
by: Jifeng Liu, et al.
Published: (2023-02-01)